Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | GABBR2 | O75899 | 3/20 | 0.62 |
| ▸ | GABBR1 | Q9UBS5 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | DRD3 | P35462 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | SCN4A | P35499 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL390335 | 1.00 | CYP2C9 (0.64) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL5721009 | 1.00 | CYP2C9 (0.64) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| Hydrochloric Acid SCHEMBL20446442 | 0.98 | CYP2C9 (0.62) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| Hydrochloric Acid SCHEMBL18130542 | 0.98 | CYP2C9 (0.62) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| Hydrochloric Acid SCHEMBL18130541 | 0.98 | CYP2C9 (0.62) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL29720969 | 0.98 | CYP2C9 (0.62) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL14785618 | 0.84 | CYP2C9 (0.50) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL390453 | 0.84 | CYP2C9 (0.50) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL19810879 | 0.84 | CYP2C9 (0.50) | CYP2C9MEN1CYP2D6CYP2C19KMT2A | |
| SCHEMBL6965546 | 0.84 | FFAR1 (0.50) | CYP2C9MEN1CYP2D6CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240092830-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | PEKING UNIVERSITY (CN) | 2024-03-21 | — | — | US | claimed |
| EP-4265600-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | Peking University (CN) | 2023-10-25 | — | — | EP | claimed |
| CN-116670120-A | Process for preparing carboxylic cyclic anhydride | 北京大学 | 2023-08-29 | — | — | CN | claimed |
| WO-2022127704-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | 北京大学 | 2022-06-23 | — | — | WO | claimed |
| CN-114634460-A | Process for preparing carboxyanhydrides | 北京大学 | 2022-06-17 | — | — | CN | claimed |
| CN-122012477-A | Phenylalanine aminomutase and application thereof in preparation of R-type beta-amino acid | 常州合全药业有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250367300-A1 | Nanomaterial and Methods of Use Thereof | UNIVERSITY OF CONNECTICUT (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250302971-A1 | Therapeutic Nanomaterials | UNIV CONNECTICUT (US) | 2025-10-02 | — | — | US | disclosed |
| US-20250229081-A1 | NANOMATERIAL COATED ELECTRODE AND METHODS OF USE THEREOF | UNIVERSITY OF CONNECTICUT | 2025-07-17 | — | — | US | disclosed |
| EP-4578868-A1 | CYCLIC PEPTIDE OR SALT THEREOF, AND MDMX INHIBITOR | FUJIFILM Corporation (JP) | 2025-07-02 | — | — | EP | disclosed |
| EP-4578867-A1 | CYCLIC PEPTIDE OR SALT THEREOF AND MDMX INHIBITOR | FUJIFILM Corporation (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-120202010-A | Ligand-oligonucleotide conjugates and linkers for use therewith | 上海京新生物医药有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-5892038-A | ENZYME INHIBITORS FOR TREATMENT OF DISEASES SUCH AS MALARIA | PHARMACOPEIA, INC. (US) | 1999-04-06 | — | — | US | disclosed |
| EP-0904401-A1 | COMBINATORIAL HYDROXYPROPYLAMINE LIBRARY | PHARMACOPEIA, INC. (US) | 1999-03-31 | — | — | EP | disclosed |
| US-5872262-A | COMPOUNDS AS INHIBITORS OF PLASMEPSIN AND CATHEPSIN | PHARMACOPEIA, INC. (US) | 1999-02-16 | — | — | US | disclosed |
| WO-1998037079-A1 | N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS | BERLEX LABORATORIES, INC. (US) | 1998-08-27 | — | — | WO | disclosed |
| US-5766963-A | IDENTIFYING BIOLOGICALLY ACTIVE MEMBERS BY SCREENING IN BIOASSAYS | PHARMACOPEIA, INC. (US) | 1998-06-16 | — | — | US | disclosed |
| WO-1998020350-A1 | COMBINATORIAL HYDROXY-AMINO ACID AMIDE LIBRARIES | PHARMACOPEIA, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
| US-5734054-A | Hydroxy-amino acid amides | PHARMACOPEIA, INC. (US) | 1998-03-31 | — | — | US | disclosed |
| WO-1997027315-A1 | COMBINATORIAL HYDROXYPROPYLAMINE LIBRARY | PHARMACOPEIA, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302971-A1 | Therapeutic Nanomaterials | TIE1, TEKT1, POLRMT | CYP2C9 4636/4885MEN1 2181/4885CYP2D6 4662/4885 |
| US-20250367300-A1 | Nanomaterial and Methods of Use Thereof | EPCAM, CD47, JAK2 | CYP2C9 1311/4885MEN1 383/4885CYP2D6 893/4885 |
| US-20240092830-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | CA9, CA7, APEH | CYP2C9 87/4885MEN1 4513/4885CYP2D6 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.